Peter J. Snyder

                                                              Peter J. Snyder, Ph.D.
Senior Vice President & Chief Research Officer, Lifespan Hospital System, Providence, RI
Professor, Department of Neurology, The Warren Alpert Medical School of Brown University, Providence, RI
Adjunct Professor, Child Study Center, Yale University School of Medicine, New Haven, CT

Professor Snyder received his doctorate in clinical psychology and behavioral neuroscience from Michigan State University in 1992, following a residency in clinical neuropsychology at the Long Island Jewish Medical Center (New York, USA).  Dr. Snyder was awarded the 1992 Wilder Penfield Fellowship by the American Epilepsy Society and the Epilepsy Foundation of America, and he served as a Clinical Neurosciences Fellow in the NIMH Clinical Research Center for the Study of Schizophrenia at Hillside Hospital (Albert Einstein College of Medicine) in 1992 and 1993.  

Dr. Snyder is an internationally known leader in the field of Alzheimer’s disease, and he publishes regularly with numerous scientific collaborators.  He served as Associate Editor of Brain and Cognition for 11 years, and he is currently a Senior Associate Editor for Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, and he has delivered nearly 200 presentations at international scientific conferences.  His academic interests and publications span a range of topics in neuropharmacology, neurophysiology, history of neuroscience and research ethics; and his clinical interests are currently focused on the topics of aging and dementia.  From 1998 through 2005, Dr. Snyder was employed as a scientist, clinician and manager at Pfizer Global Research & Development – Groton Laboratories (Connecticut, USA) – the largest research laboratory of Pfizer Inc.  Dr. Snyder was responsible for the identification and development of novel clinical technologies and biomarkers for the CNS therapeutic area at Pfizer.  Then, as a Director and Early Clinical Leader at Pfizer, Dr. Snyder led the development of novel compounds for the treatment of schizophrenia and Alzheimer’s disease.

Dr. Snyder left Pfizer in 2005, to return to academia as a Professor (with tenure) in the Departments of Psychology and Neurology at the University of Connecticut (Storrs & Farmington, CT).  In 2008 Dr. Snyder accepted a position as the Sr. Vice President & Chief Research Officer for the major affiliate teaching hospitals of the Warren Alpert Medical School of Brown University (Providence, RI), where he also serves as a Professor in the Department of Neurology.  In this current capacity, Dr. Snyder is responsible for a portfolio of $82MM in annual external funding, and the oversight of nearly 1,000 faculty and staff (combined) who are engaged in research across the hospital system.  

Dr. Snyder is an active adjunct faculty member in the Yale Child Study Center, Yale University School of Medicine, and he currently serves as the major professor for several honors undergraduate, graduate and post-doctoral students.  He is a Fellow of the American Psychological Association (Div. 40, Clinical Neuropsychology; Div. 6, Behavioural Neuroscience), and he is the recipient of the 2001 Distinguished Early Career Contributions Award from the National Academy of Neuropsychology.  Dr. Snyder is the Senior Editor of a best-selling handbook on clinical neuropsychological practice that is published by the American Psychological Association (APA Books, Inc.).